Chimeric antigen receptor (CAR) T cell therapy has emerged as a revolutionary approach in the treatment of certain cancers. However,...

Chemotherapy-induced peripheral neuropathy (CIPN) remains one of the most challenging side effects faced by breast cancer patients undergoing taxane-based chemotherapy....

Han Xiao of Rice University has been distinguished with the David W. Robertson Award for Excellence in Medicinal Chemistry, a...

In recent years, the advent of genetically engineered chimeric antigen receptor (CAR) T cell therapy has revolutionized the landscape of...

In a groundbreaking phase Ib clinical trial published in BMC Cancer, researchers have unveiled promising results exploring the combination of...

A groundbreaking advancement in breast cancer risk prediction technology has taken a significant leap forward with the acquisition of Prognosia,...

In a groundbreaking pooled analysis published in BMC Cancer, an international team of researchers has illuminated a promising therapeutic strategy...

A groundbreaking international study led by the Alliance for Clinical Trials in Oncology alongside the Acute Myeloid Leukemia Cooperative Group...

In a groundbreaking study poised to reshape the landscape of head and neck cancer treatment, researchers have illuminated the pivotal...

In the evolving landscape of cancer treatment, chemotherapy remains a cornerstone strategy despite its notorious side effects, among which chemotherapy-induced...